SLN
Silence Therapeutics
SLN
SLN
28 hedge funds and large institutions have $188M invested in Silence Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
28
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$7.86M | |
| 2 | +$2.32M | |
| 3 | +$280K | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$76.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.5K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$1.23M | |
| 3 | -$714K | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$520K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$477K |